Abboud, M., Kanter, J., Marfo, K., Anthony, C., Lincy, J., Nassin, M., . . . Ataga, K. I. (2023, August). PB2512: SAFETY OF CRIZANLIZUMAB IN PATIENTS WITH SICKLE CELL DISEASE: INTEGRATED POST-MARKETING SURVEILLANCE ANALYSIS. HemaSphere.
芝加哥风格引文Abboud, Miguel, et al. "PB2512: SAFETY OF CRIZANLIZUMAB IN PATIENTS WITH SICKLE CELL DISEASE: INTEGRATED POST-MARKETING SURVEILLANCE ANALYSIS." HemaSphere Aug. 2023.
MLA引文Abboud, Miguel, et al. "PB2512: SAFETY OF CRIZANLIZUMAB IN PATIENTS WITH SICKLE CELL DISEASE: INTEGRATED POST-MARKETING SURVEILLANCE ANALYSIS." HemaSphere, Aug. 2023.
警告：这些引文格式不一定是100％准确.